Home › NCT05694663

Vagal Nerve Stimulation in Enhanced Stroke Recovery: The VALOR Registry

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Provision of signed and dated informed consent form
* Stated willingness to comply with all procedures in the VNS-Enhanced Stroke Recovery Program
* Aged 18 or older
* History of ischemic stroke
* Upper extremity weakness
* Planned to undergo VNS implantation

Exclusion Criteria:

* Unfavorable candidacy for device implant surgery (e.g., history of adverse reactions to anesthetics, poor surgical candidate in surgeon's opinion, prior injury to the vagus nerve etc.).
* Medical or mental instability (diagnosis of personality disorder, psychosis, or substance abuse) that would prevent the subject from meeting protocol timeline.

About the study

Vagal Nerve Stimulation is a novel proven therapy for patients with chronic ischemic stroke. The primary objective of this registry is to assess the safety of vagal nerve stimulation for stroke recovery through monitoring the occurrence of serious adverse events associated with the surgical procedure or subsequent paired rehabilitation protocol. This registry will monitor patients undergoing VNS for stroke recovery in the Mount Sinai Health System and collect clinical and procedural details, objective outcomes, and patient-reported outcomes associated with vagal nerve stimulation for stroke recovery.

What is being tested

• Vivistim (device)

Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 40 · Started: Oct 9, 2024

Contact the study team

• Emily Svendsen · Phone: (212) 241-3238
• Sydney Edwards · Phone: (212) 241-2524

Official record on ClinicalTrials.gov — NCT05694663

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.